---
title: "Recombinate Health Co-Invest I, LLC SEC filings"
url: https://altstreet.investments/edgar/2160709
kind: edgar-entity
updated: 2026-11-05
publisher: AltStreet (https://altstreet.investments)
license: Public factual pages may be read, quoted and cited with attribution and a link. Bulk redistribution is not permitted.
---

# Recombinate Health Co-Invest I, LLC: SEC filings and what they report

Recombinate Health Co-Invest I, LLC is a Delaware-formed pooled investment fund that filed a Form D on 2026-11-04 under the 506(b) exemption combined with the 3(c)(1) exclusion, raising $2.9M from 26 investors. The filing was submitted by related parties Recombinate Health LLC (Director) and executives/promoters Matthew Hollingsworth and Matthew Survis; minimum investment and first sale date were not disclosed on the filing, and no parent platform has been matched.

| Field | Value |
| --- | --- |
| Entity | Recombinate Health Co-Invest I, LLC |
| CIK | 2160709 |
| Filing family | 506(b), 3(c)(1) |
| Entity type | co invest |
| Manager (as filed) | Recombinate Health |
| Newest fact-bearing filing | November 4, 2026, accession 0002160709-26-000001 |
| Total sold (as reported) | $2,910,000 |
| Investors (as reported) | 26 |
| Vintage | 2026 |

## Related persons (Form D Item 3)

| Name | Relationship |
| --- | --- |
| n/a Recombinate Health LLC | Director |
| Matthew Hollingsworth | Executive Officer, Promoter |
| Matthew Survis | Executive Officer, Promoter |


## More

- Entity page (HTML, with events, parties and the platform record): https://altstreet.investments/edgar/2160709
- SEC EDGAR filing index: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002160709&owner=include&count=40
- Signal history, evidence passages and the entity graph are AltStreet Terminal features: https://altstreet.investments/terminal

---

Source page: https://altstreet.investments/edgar/2160709
Machine index: https://altstreet.investments/llms.txt
AltStreet reads what platforms, funds and issuers file with the SEC and what they tell investors, and publishes the difference. Figures are as filed or as captured on the date stated; nothing here is investment advice.